Allen Meacham

Mr. Meacham has served as the Chief Revenue Officer since September 2020. Mr. Meacham previously held a number of roles at Boston Scientific Corporation from January 2005 to September 2020, most recently as Vice President of US Neuromodulation, from June 2016 to September 2020. Mr. Meacham previously worked for Abbott Diagnostics, Bayer Diagnostics, and GlaxoSmithKline from 1992 to 2005 in various sales, sales management, marketing, and sales training positions. He received a B.S. in Business Administration from the University of Arkansas at Fayetteville and completed the Advanced Management Program at Harvard Business School.